NLVP
New Leaf Venture Partners Portfolio holdings
AUM
$52.9M
This Quarter Return
-11.65%
1 Year Return
-33.65%
3 Year Return
+15.24%
5 Year Return
+39.89%
10 Year Return
+615.06%
AUM
$74.8M
AUM Growth
+$74.8M
(-23%)
Cap. Flow
-$11.3M
Cap. Flow
% of AUM
-15.12%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
1
Reduced
1
Closed
1
Top Buys
| 1 |
Arvinas
ARVN
|
$2.89M |
Top Sells
| 1 |
Edgewise Therapeutics
EWTX
|
$14M |
| 2 |
X4 Pharmaceuticals
XFOR
|
$224K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Arvinas
ARVN
$568M
| $30.4M | 40.64% | 1,585,721 +151,000 | +11% | +$2.89M |
|
|
2
Edgewise Therapeutics
EWTX
$1.51B
| $27.5M | 36.77% | 1,030,161 -523,500 | -34% | -$14M |
|
3
Crinetics Pharmaceuticals
CRNX
$2.92B
| $7.21M | 9.64% | 141,000 | – | – |
|
4
Rallybio
RLYB
$22.4M
| $3.17M | 4.24% | 3,301,603 | – | – |
|
5
Cogent Biosciences
COGT
$1.69B
| $1.96M | 2.61% | 250,765 | – | – |
|
6
Rocket Pharmaceuticals
RCKT
$354M
| $1.89M | 2.53% | 150,706 | – | – |
|
7
Passage Bio
PASG
$22.7M
| $1.42M | 1.89% | 2,497,922 | – | – |
|
8
Alector
ALEC
$238M
| $642K | 0.86% | 339,569 | – | – |
|
9
Iterum Therapeutics
ITRM
$30.2M
| $611K | 0.82% | 345,020 | – | – |
|
|
10
X4 Pharmaceuticals
XFOR
$84.2M
| – | – | -335,000 | Closed | -$224K |
|